@article {3321,
	title = {Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners.},
	journal = {PloS one},
	volume = {7},
	year = {2012},
	month = {2012},
	pages = {e38335},
	abstract = {HIV-infected prisoners lose viral suppression within the 12 weeks after release to the community. This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD).},
	keywords = {Adult, Buprenorphine, Female, HIV Infections, Humans, Male, Middle Aged, Naloxone, Opioid-Related Disorders, Prisoners, Prospective Studies, Treatment Outcome},
	issn = {1932-6203},
	doi = {10.1371/journal.pone.0038335},
	author = {Springer, Sandra A and Qiu, Jingjun and Saber-Tehrani, Ali Shabahang and Altice, Frederick L}
}
